Informe del Mercado de Suplementos para la Salud Ocular por Tipo de Ingrediente (Luteína y Zeaxantina, Antioxidantes, Ácidos Grasos Omega-3, Coenzima Q10, Flavonoides, Ácido Alfa-Lipoico y Otros), Indicación (Degeneración Macular Relacionada con la Edad (AMD), Cataratas, Síndrome del Ojo Seco, Inflamación y Otros), Formulación (Tabletas, Cápsulas, Polvo y Otros) y Región 2024-2032

Informe del Mercado de Suplementos para la Salud Ocular por Tipo de Ingrediente (Luteína y Zeaxantina, Antioxidantes, Ácidos Grasos Omega-3, Coenzima Q10, Flavonoides, Ácido Alfa-Lipoico y Otros), Indicación (Degeneración Macular Relacionada con la Edad (AMD), Cataratas, Síndrome del Ojo Seco, Inflamación y Otros), Formulación (Tabletas, Cápsulas, Polvo y Otros) y Región 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A17467

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Eye Health Supplements Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Ingredient Type
    6.1    Lutein and Zeaxanthin
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Antioxidants
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Omega-3 Fatty Acids
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Coenzyme Q10
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Flavonoids
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Alpha-Lipoic Acid
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Others
        6.7.1 Market Trends
        6.7.2 Market Forecast
7   Market Breakup by Indication
    7.1    Age-related Macular Degeneration (AMD)
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cataract
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Dry Eye Syndrome
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Inflammation
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Formulation
    8.1    Tablets
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Capsules
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Powder
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Alliance Pharma PLC
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Amway International (Alticor)
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Bausch & Lomb Incorporated
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Eyescience Labs
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Kemin Industries Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Novartis AG
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    NutraChamps
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Nutrivein
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Pfizer Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    The Nature's Bounty Co.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
        14.3.11    Vitabiotics Ltd.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
        14.3.12    ZeaVision LLC
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio

Informe del Mercado de Suplementos para la Salud Ocular por Tipo de Ingrediente (Luteína y Zeaxantina, Antioxidantes, Ácidos Grasos Omega-3, Coenzima Q10, Flavonoides, Ácido Alfa-Lipoico y Otros), Indicación (Degeneración Macular Relacionada con la Edad (AMD), Cataratas, Síndrome del Ojo Seco, Inflamación y Otros), Formulación (Tabletas, Cápsulas, Polvo y Otros) y Región 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials